Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer's ...

A recent study has found that dronabinol, a synthetic version of THC (the primary psychoactive component in cannabis), ...

An FDA-approved synthetic version of THC (the main ingredient in cannabis) reduces agitation in patients with Alzheimer's ...

A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows.

Agitation is one of the most distressing symptoms of Alzheimer's dementia, and we are pleased to make positive strides forward in treatment of these patients." Paul Rosenberg, M.D., professor of ...

The rate of antipsychotic drug use in nursing homes has remained stubbornly high. Experts are concerned about misuse.

Anxiety and depression are significant risk factors for AD, and conversely, AD increases the likelihood of developing these psychiatric conditions. A systematic review of 14,760 studies showed ...

"While further analyses are needed to better understand predictors of treatment ... The Alzheimer's Association has tips to help families cope with a loved one's anxiety and agitation.

"It is the agitation, not the memory loss, that often drives individuals with dementia to the emergency ... needed to better understand predictors of treatment response to help inform subsequent ...

Synthetic THC -- the psychoactive compound in cannabis -- eased anxiety in people with Alzheimer's disease Stressed-out ... better understand predictors of treatment response to help inform ...